Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Successful management of an inadvertent excessive treprostinil overdose.

Hohenforst-Schmidt W, Hornig J, Friedel N, Zarogoulidis P, Zarogoulidis K, Brachmann J.

Drug Des Devel Ther. 2013 Mar 21;7:161-5. doi: 10.2147/DDDT.S42771. Print 2013.

PMID:
23662045
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A pediatric case study of treprostinil overdose.

Walsh M, Hanna BD.

J Heart Lung Transplant. 2009 Mar;28(3):297-8. doi: 10.1016/j.healun.2008.12.006.

PMID:
19285625
[PubMed - indexed for MEDLINE]
3.

Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics.

Siehr SL, Ivy DD, Miller-Reed K, Ogawa M, Rosenthal DN, Feinstein JA.

J Heart Lung Transplant. 2013 May;32(5):546-52. doi: 10.1016/j.healun.2013.01.1055. Epub 2013 Feb 28.

PMID:
23453572
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension.

Sadushi-Koliçi R, Skoro-Sajer N, Zimmer D, Bonderman D, Schemper M, Klepetko W, Glatz J, Jakowitsch J, Lang IM.

J Heart Lung Transplant. 2012 Jul;31(7):735-43. doi: 10.1016/j.healun.2012.02.025. Epub 2012 Apr 4.

PMID:
22480725
[PubMed - indexed for MEDLINE]
5.

Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension.

Budev MM, Minai OA, Arroliga AC.

Drugs Today (Barc). 2004 Mar;40(3):225-34. Review.

PMID:
15148531
[PubMed - indexed for MEDLINE]
6.

Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease.

Sakai T, Planinsic RM, Mathier MA, de Vera ME, Venkataramanan R.

Transpl Int. 2009 May;22(5):554-61. doi: 10.1111/j.1432-2277.2008.00830.x. Epub 2008 Jan 19.

PMID:
19175541
[PubMed - indexed for MEDLINE]
7.

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, Oudiz R, Frost A, Blackburn SD, Crow JW, Rubin LJ; Treprostinil Study Group.

Am J Respir Crit Care Med. 2002 Mar 15;165(6):800-4.

PMID:
11897647
[PubMed - indexed for MEDLINE]
8.

[Long-term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic].

Jansa P, Ambroz D, Maresová J, Jelínková L, Polácek P, Palecek T, Aschermann M, Linhart A.

Vnitr Lek. 2007 Apr;53(4):333-7. Czech.

PMID:
17578162
[PubMed - indexed for MEDLINE]
9.

Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension.

Lang I, Gomez-Sanchez M, Kneussl M, Naeije R, Escribano P, Skoro-Sajer N, Vachiery JL.

Chest. 2006 Jun;129(6):1636-43.

PMID:
16778286
[PubMed - indexed for MEDLINE]
10.

Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.

Keogh AM, Jabbour A, Weintraub R, Brown K, Hayward CS, Macdonald PS.

J Heart Lung Transplant. 2007 Nov;26(11):1079-83. Epub 2007 Oct 24.

PMID:
18022071
[PubMed - indexed for MEDLINE]
11.

The role of treprostinil in the management of pulmonary hypertension.

Skoro-Sajer N, Lang I.

Am J Cardiovasc Drugs. 2008;8(4):213-7.

PMID:
18690755
[PubMed - indexed for MEDLINE]
12.

Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.

McLaughlin VV, Gaine SP, Barst RJ, Oudiz RJ, Bourge RC, Frost A, Robbins IM, Tapson VF, McGoon MD, Badesch DB, Sigman J, Roscigno R, Blackburn SD, Arneson C, Rubin LJ, Rich S; Treprostinil Study Group.

J Cardiovasc Pharmacol. 2003 Feb;41(2):293-9.

PMID:
12548091
[PubMed - indexed for MEDLINE]
13.

Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.

Benza RL, Rayburn BK, Tallaj JA, Pamboukian SV, Bourge RC.

Chest. 2008 Jul;134(1):139-45. doi: 10.1378/chest.07-2111. Epub 2008 Apr 10.

PMID:
18403673
[PubMed - indexed for MEDLINE]
14.

The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.

Gessler T, Seeger W, Schmehl T.

Ther Adv Respir Dis. 2011 Jun;5(3):195-206. doi: 10.1177/1753465810397693. Epub 2011 Feb 7. Review.

PMID:
21300738
[PubMed - indexed for MEDLINE]
15.

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.

Tapson VF, Gomberg-Maitland M, McLaughlin VV, Benza RL, Widlitz AC, Krichman A, Barst RJ.

Chest. 2006 Mar;129(3):683-8.

PMID:
16537868
[PubMed - indexed for MEDLINE]
16.

Staggered transition to epoprostenol from treprostinil in pulmonary arterial hypertension.

Reisbig KA, Coffman PA, Floreani AA, Bultsma CJ, Olsen KM.

Ann Pharmacother. 2005 Apr;39(4):739-43. Epub 2005 Mar 8.

PMID:
15755791
[PubMed - indexed for MEDLINE]
17.

Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.

Benza RL, Seeger W, McLaughlin VV, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubin LJ.

J Heart Lung Transplant. 2011 Dec;30(12):1327-33. doi: 10.1016/j.healun.2011.08.019.

PMID:
22055098
[PubMed - indexed for MEDLINE]
18.

Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.

Gomberg-Maitland M, Tapson VF, Benza RL, McLaughlin VV, Krichman A, Widlitz AC, Barst RJ.

Am J Respir Crit Care Med. 2005 Dec 15;172(12):1586-9. Epub 2005 Sep 8.

PMID:
16151039
[PubMed - indexed for MEDLINE]
19.

Inhaled treprostinil for the treatment of pulmonary arterial hypertension.

LeVarge BL, Channick RN.

Expert Rev Respir Med. 2012 Jun;6(3):255-65. doi: 10.1586/ers.12.23. Review.

PMID:
22788940
[PubMed - indexed for MEDLINE]
20.

Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension.

de Jesus Perez VA, Rosenzweig E, Rubin LJ, Poch D, Bajwa A, Park M, Jain M, Bourge RC, Kudelko K, Spiekerkoetter E, Liu J, Hsi A, Zamanian RT.

Am J Cardiol. 2012 Nov 15;110(10):1546-50. doi: 10.1016/j.amjcard.2012.07.012. Epub 2012 Jul 30.

PMID:
22853986
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk